A novel rapamycin analog is highly selective for mTORC1 in vivo
Katherine H. Schreiber(Buck Institute for Research on Aging), Dudley W. Lamming(University of Wisconsin–Madison)
Cited by 196
Related Papers
Rapalogs and mTOR inhibitors as anti-aging therapeutics
|Journal of Clinical Investigation|2013|536
Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic Health
|Cell Reports|2016|476
Rapamycin‐mediated <scp>mTORC</scp> 2 inhibition is determined by the relative expression of <scp>FK</scp> 506‐binding proteins
|Aging Cell|2015|173
Non-canonical metabolic and molecular effects of calorie restriction are revealed by varying temporal conditions
|Cell Reports|2024|13
Non-canonical Metabolic and Molecular Effects of Calorie Restriction Are Revealed by Varying Temporal Conditions
|bioRxiv (Cold Spring Harbor Laboratory)|2024|2